https://www.avient.com/sites/default/files/2023-09/Avient Sustainability Day 2023 - Website %289.19%29.pdf
CAFE: Corporate Average Fuel Economy
>50% Improvement
REDUCE – TAKEAWAY
Reducing Energy Consumption and Dependence on Fossil Fuels Drives Growth Projections
Examples
Covered
45%
Other
Applications
2022PF
$310M
38
46
CAFE1 Miles Per Gallon Proposed Requirements
HOW WE ENABLE SUSTAINABILITY
Preserve
Woon Keat Moh
Senior Vice President, President of Color, Additives and Inks –
Americas and Asia
Avient Corporation 61
PRESERVE
Avient Corporation 62
• Preserving Key Natural Resources - Companies are being challenged to
mitigate high environmental impact processes such as water-intensive textile dyeing or
food spoilage
• Incorporating Renewable Materials - Adoption of bio-based raw materials
requires design and formulation expertise to overcome performance shortcomings of
neat resins
• Increasing Healthcare Regulations - Utilizing sustainable materials in
healthcare applications requires considerable support in navigating complex regulatory
requirements
• Increasing Regulatory Compliance - Non-Intentionally Added Substances
(NIAS) need to be controlled in sensitive applications
• Enabling Faster and More Reliable Connectivity – Substantial investments
in 5G infrastructure are required to unlock the potential of the Internet of Things
Solutions to preserve and
protect natural resources &
human life
Avient Corporation 63
Spin Dyed Precolor Textile Yarn
Renol™ Spin Dyeing Colorants
• Replaces water-based dye processes to reduce
waste creation
• Conserves water and energy
LESS WATER
PROTECTIVE DENIM
Dyneema® Workwear Solutions
• Improves tear resistance 50-100%
• More protective than competitive alternatives
• Enables the amount of protective fiber to be
reduced without sacrificing performance
600%
IMPROVED ABRASION RESISTANCE
Clothing & Textiles
2022 Revenue: $49M
Avient Corporation 64
Low Cure Textile Inks
Avient Specialty Inks™ Low Cure Inks
• Decreases energy consumption
• Reduces scrap due to heat-related defects
SAVES ENERGY
Clothing & Textiles
2022 Revenue: $40M
BIO-BASED
FORMULATIONS
Water Based Textile Inks
Zodiac™ Aquarius™ Specialty Inks
• Incorporates bio-based materials
• Non-formaldehyde solutions available
• Reduces waste by enabling high open screen time
Avient Corporation 65
Mosquito Netting
Cesa™ Fiber Anti-Mosquito Additives
• Helps control malaria
• Protects consistently using a controlled
release of insecticide
• Expands access to healthcare
breakthroughs to global communities
ANNUAL NEW MALARIA CASES
200 Million
Antimicrobial Protection
Cesa™ WithStand™ Antimicrobial Additives
• Reduces microbial / mold growth
• Helps reduce odor, staining, discoloration
• Excellent comfort and wearability
• Chemical resistance - will not discolor
or degrade
REDUCES MICROBES
2022 Revenue: $5M
Avient Corporation 66
Cut-Resistant Gloves
Dyneema® Solutions
• Incorporates bio-based materials
• Reduces carbon emissions
• Excellent wearability / comfort
WORK INJURIES
REDUCES
Rescue Rope
Dyneema® Solutions
• Superior strength-to-weight ratio
• High break load
• Extraordinary reliability
SAVES LIVES
2022 Revenue: $106M
Body Armor
Dyneema® Protective Solutions
• Exceptional trauma protection
• Excellent wearability
LIGHTER
THAN ARAMID FIBER
35%
Avient Corporation 67
BIO-DERIVED
Pharmaceutical Tubing
Versaflex™ Healthcare Pharma Tubing Formulations
NEU™ Specialty Engineered Materials
• Facilitates incorporation of sustainable materials
with healthcare device manufacturers
• Eliminates vulcanization processes
Medical
2022 Revenue: $40M
NON-PHTHALATE
Respiratory Conduit
Versaflex™ Healthcare Corrugated
Tubing Formulations
• Non-Phthalate
• ISO 10993 & USP Class VI compliant
Avient Corporation 68
UP TO
BIO-BASED CARRIER
Medical Devices
Mevopur™ Bio-Based Colorants
• Minimizes risk through pre-testing
• Provides vital regulatory compliance
• Minimizes global supply chain risk with
validated backup supply
Continuous Glucose Monitoring
and Auto Injectors
Trilliant™ Healthcare Polymer Solutions
• Impact performance
• Chemical resistance
ENABLES HOME CARE
Medical
2022 Revenue: $16M
Avient Corporation 69
Fiber Optic Cable and Jacketing
Fiber-Line™ Optical Fiber Cable Components
• Reduction in weight & energy usage
• Thermal and abrasion resistant
• Extends product life
ENABLES CONNECTIVITY
Cable Micromodules
ECCOH™ Low Smoke Formulations
• Non-halogen
• Low smoke and toxicity
SUPPORTS SUSTAINABLE
INFRASTRUCTURE
Base Station Components
Edgetek™ Low-Density Formulations
• Low density – lighter weight
• Low warpage & thermal conductivity
EXTENDS PRODUCT LIFE
Antenna Components
PREPERM™ Low Loss
Dielectric Formulations
• Replaces costly ceramics
• Consistent and efficient antenna performance
ENHANCES
PERFORMANCE
5G Infrastructure
2022 Revenue: $39M
Avient Corporation 70
“Nike has partnered with Avient extensively over the years because of their leadership in
eco-friendly screen printing inks.”
Per Carlsson, Manufacturing and Operations
Avient Corporation 71
80
2022 2030
Medical Plastics Market Size
PRESERVE – TAKEAWAY
Protecting Human Life and Enabling Connectivity Drives Growth Projections
Examples
Covered
56%
Other Applications
44%
2022
$525M (in
$
Bi
lli
s)
8% CAGR 34% CAGR
5G Infrastructure Market Size
12
92
10
70
80
2023 2024 2025 2026 2027 2028 2029 2030
(in
$
Bi
lli
s)
Source: Grand View Research Source: Global Data
Summary
Senior Vice President and Chief Financial Officer
Avient Corporation 72
OUR SUSTAINABILITY REPORT
Avient Corporation 73
Avient Corporation 74
2030 SUSTAINABILITY GOALS
Avient Corporation 75
PERFORMANCE AND RECOGNITION
1
2
5
ESG Ratings Performance
ESG Awards and Certifications
top 13%
94th
percentile
Avient Corporation 76
SUSTAINABILITY INNOVATION AWARDS
Ultra-Low Carbon
Footprint TPE
Innovation Award, Finalist:
PCR Colorants + Additives
Sustainable Packaging Innovation,
Finalist: U.S.
Plastics Pact
Post-Consumer Recycle (PCR)
Color Predictive Tool
Innovation Award, Winner:
Product Technology Innovation, Winner:
Plastics Recycling Awards Europe 2023
Additive for
Enhanced Recycling
Innovation Award, Finalist:
Product Technology Innovation, Finalist:
Plastics Recycling Awards Europe 2023
Service Innovation
Enables Quality Recycle
Product Innovation
Enables PCR Claims + Low CO2
Product Innovation
Protects Quality Recycle
…are Growing at Twice the Rate as
Conventional ProductsSustainably-Branded Products…
Consumers
Are demanding
recyclability and eco-
conscious products
Governments
Are mandating changes
through legislation, taxes,
and regional accords
STAKEHOLDER INFLUENCE DRIVES DEMAND
For Sustainable Products From Sustainable Companies
Brand Owners
Have committed to ambitious
goals to achieve
sustainability metrics
Avient Corporation 77
Avient Corporation 78
SUSTAINABILITY TRENDS DRIVE LONG-TERM GROWTH
8-12%
Long Term
Growth
18
46
2023 2032
Global Offshore Annual
Wind Installations
(in Gigawatts)
2022 2030
Medical Plastics
Market Size
(in $Billions)
12% CAGR
3% CAGR
Recycled
Virgin
Growing Demand for
Recycled Content
Avient Sustainable
Solutions
11% CAGR
8% CAGR
Sources: McKinsey, Bloomberg, Grand View Research
Avient Corporation 79
Increasing the use
of recycled content
Reducing weight to
lower fuel consumption
2022 SALESDESCRIPTION
$340M
$310M
$525M
OUTCOMES
Enabling customers to
advance the circular economy
Shrinking carbon footprint
and decreasing emissions
Making our planet a better
place for all
Using fewer natural resources;
protecting human life
$1,175MTOTAL SALES
SUSTAINABILITY TRENDS DRIVE LONG-TERM GROWTH
AVIENT IS WELL-POSITIONED
A Clean House
Avient holds leading ratings on
ESG matters of importance to
customers, countries, and
key stakeholders
Leading Portfolio
Our formulation expertise and materials
are meeting the unique sustainability
needs of our customers around the world
in endless applications
8-12% Long-Term Growth RateAvient’s Sustainable Solutions
Investing in Innovation
85% of our opportunity funnel is
directed at sustainable solutions
addressing unmet customer needs
Avient Corporation 80
Avient Corporation 81
ADJUSTED EBITDA MARGIN EXPANSION
• Transformative acquisitions
combined with divestitures of
more cyclical businesses have
improved margins over 400 bps
since 2018
• 20% long-term margin goal to be
driven by key growth drivers, with
sustainable solutions playing a
meaningful role
5.4%
11.5%
16.0%
17.3%
20% 20.0%
2006 2018 2023E Recovery Growth
Drivers
Strategic
Objective
20%+
+1%+
+3%+
Community Service
7x Safer
than Industry Average
World-Class Safety
Leadership Development
Over $19 million
raised since 2007
Diversity & Inclusion
PEOPLE AND CULTURE
Avient Corporation 82
Avient Corporation 83
• 6% annualized long-term sales growth leveraging
sustainable solutions, composites, healthcare, and
emerging regions
• Expand EBITDA margins to 20%
• Deliver annual EBITDA and EPS growth of
10% and 15%
• Maintain asset-light, 80% free cash flow conversion
profile and be valued as a specialty formulator
• Continue fostering our Great Place to Work® culture
LONG-TERM OBJECTIVES
Avient Corporation 84
Wrap Up and Q + A
Chairman, President, and Chief Executive Officer
Avient Corporation 85
Investor Deck_9_19_23 v4_WEBSITE_GAAP.pdf
2023 SR Non-GAAP Rec v3
https://www.avient.com/sites/default/files/resources/PolyOne%2520Investor%2520Presentation%2520Jefferies%25202013%2520Global%2520Industrial%2520Conference_Posting.pdf
EPS: $1.00
$0.54
$0.68
$0.30
$0.45
$0.60
$0.75
H1'12 H1'13
Adjusted EPS
$101.0
$132.6
$50.0
$100.0
$150.0
H1'12 H1'13
Adjusted Operating Income
(millions)
+31%
$68.8
$97.7
$50.0
$75.0
$100.0
H1'12 H1'13
Specialty Operating Income
(millions)
First Half 2013 Financial Highlights
• Adjusted EPS increased 26% over prior
year first half
• Operating Income expanded 31%
versus first half 2012
• Specialty operating income up 42%
• Revenue grew 22% versus 1H ‘12
• Portfolio transformation activities
Completed acquisition of Spartech
Divested non-core Resin business
+26%
+42%
Page 12
• Significant Debt Maturities $ 1,010
Other Debt 21
• Total Debt at 6/30/13
Less: Cash
Net Debt
• Available Liquidity
Cash
ABL Availability
Total Liquidity
• Net Debt / EBITDA = 1.9x*
• Net Debt / EBITDA = 2.1x*(tax adjusted)
$392
310
$702
$1,031
392
$639
$50
$360
$600
$0
$100
$200
$300
$400
$500
$600
$700
$800
2015 2020 2023
Significant Debt Maturities
As of June 30, 2013
($ millions)
Page 13
Coupon Rates: 7.500% 7.375% 5.250%
*Pro Forma TTM
Debt Maturities & Liquidity Summary – 6/30/13
Cash Balance = $392M
Net Debt / EBITDA* = 1.9x
• Repurchased
~3.0M shares
YTD in 2013
• 17 million shares
are available for
repurchase under
the current
authorization
Share
Repurchase
• Introduced a
quarterly dividend
in Q1 2011 and
increased in Q1
2012 (25%) and
Q1 2013 (20%)
• Objective of
maintaining and
growing
Dividends
• Expanding our
sales, marketing,
and technical
capabilities is top
priority
• Investing in
operational and
LSS initiatives
(including synergy
capture)
• CAPEX
Organic
Growth
• Targets that expand our:
• Specialty offering
• End market presence
• Geographic footprint
• Synergy opportunities
• Adjacent material solutions
• North American
manufacturing alignment
Acquisitions
*TTM 6/30/2013
Use of Cash
Page 14
Why Invest In PolyOne?
https://www.avient.com/sites/default/files/resources/Credit%2520Suisse%2520June%252026%25202013.pdf
EPS: $1.00
First Quarter Financial Highlights
• 14th consecutive quarter of double digit adjusted earnings per
share growth
• 29 percent increase in adjusted EPS
34 percent increase in Specialty operating income
Growth from all regions
Virtually all organic growth
• Strengthened our financial
position
Page 13
• Total Debt at 3/31/13
Less: Cash
Net Debt
• Available Liquidity
Cash
ABL Availability
Total Liquidity
• Net Debt / EBITDA = 2.7x*
$169
285
$454
$1,056
169
$887
$50
$360
$600
$0
$100
$200
$300
$400
$500
$600
$700
$800
2015 2020 2023
Debt Maturities
As of March 31, 2013
($ millions)
Page 14
Coupon Rates: 7.500% 7.375% 5.250%
*Pro Forma TTM with no synergies related to Spartech acquisition & excludes resin assets
Debt Maturities & Liquidity Summary – 3/31/13
Cash Balance = $169M
Net Debt / EBITDA* = 2.7x
• Repurchased
840k shares in Q1
2013
• 19.1 million
shares are
available for
repurchase under
the current
authorization
Share
Repurchase
• Introduced a
quarterly dividend
in Q1 2011 and
increased in Q1
2012 (25%) and
Q1 2013 (20%)
• Objective of
maintaining and
growing
Dividends
• Expanding our
sales, marketing,
and technical
capabilities is top
priority
• Investing in
operational and
LSS initiatives
(including synergy
capture)
• CAPEX
Organic
Growth
• Targets that expand our:
• Specialty offering
• End market presence
• Geographic footprint
• Synergy opportunities
• Adjacent material solutions
Acquisitions
*TTM with no synergies related to the Spartech acquisition
Use of Cash
Page 15
Why Invest In PolyOne?
https://www.avient.com/sites/default/files/resources/dB%2520June%2520Presentation%2520June%252012%25202013%2520%25282%2529.pdf
EPS: $1.00
First Quarter Financial Highlights
• 14th consecutive quarter of double digit adjusted earnings per
share growth
• 29 percent increase in adjusted EPS
34 percent increase in Specialty operating income
Growth from all regions
Virtually all organic growth
• Strengthened our financial
position
Page 12
• Total Debt at 3/31/13
Less: Cash
Net Debt
• Available Liquidity
Cash
ABL Availability
Total Liquidity
• Net Debt / EBITDA = 2.7x*
$169
285
$454
$1,056
169
$887
$50
$360
$600
$0
$100
$200
$300
$400
$500
$600
$700
$800
2015 2020 2023
Debt Maturities
As of March 31, 2013
($ millions)
Page 13
Coupon Rates: 7.500% 7.375% 5.250%
*Pro Forma TTM with no synergies related to Spartech acquisition & excludes resin assets
Debt Maturities & Liquidity Summary – 3/31/13
Cash Balance = $169M
Net Debt / EBITDA* = 2.7x
• Repurchased
840k shares in Q1
2013
• 19.1 million
shares are
available for
repurchase under
the current
authorization
Share
Repurchase
• Introduced a
quarterly dividend
in Q1 2011 and
increased in Q1
2012 (25%) and
Q1 2013 (20%)
• Objective of
maintaining and
growing
Dividends
• Expanding our
sales, marketing,
and technical
capabilities is top
priority
• Investing in
operational and
LSS initiatives
(including synergy
capture)
• CAPEX
Organic
Growth
• Targets that expand our:
• Specialty offering
• End market presence
• Geographic footprint
• Synergy opportunities
• Adjacent material solutions
Acquisitions
*TTM with no synergies related to the Spartech acquisition
Use of Cash
Page 14
Why Invest In PolyOne?
https://www.avient.com/sites/default/files/resources/POL%2520Credit%2520Suisse%2520IR%2520Presentation%2520w%2520non-GAAP%25209%252017%25202013.pdf
EPS: $1.00
$0.54
$0.68
$0.30
$0.45
$0.60
$0.75
H1'12 H1'13
Adjusted EPS
$101.0
$132.6
$50.0
$100.0
$150.0
H1'12 H1'13
Adjusted Operating Income
(millions)
+31%
$68.6
$97.7
$50.0
$75.0
$100.0
H1'12 H1'13
Specialty Operating Income
(millions)
First Half 2013 Financial Highlights
• Adjusted EPS increased 26% over prior
year first half
• Operating Income expanded 31%
versus first half 2012
• Specialty operating income up 42%
• Revenue grew 22% versus 1H ‘12
• Portfolio transformation activities
Completed acquisition of Spartech
Divested non-core Resin business
+26%
+42%
Page 12
• Significant Debt Maturities $ 1,010
Other Debt 21
• Total Debt at 6/30/13
Less: Cash
Net Debt
• Available Liquidity
Cash
ABL Availability
Total Liquidity
• Net Debt / EBITDA = 1.9x
• Net Debt / EBITDA = 2.1x*(tax adjusted)
$392
310
$702
$1,031
392
$639
$50
$360
$600
$0
$100
$200
$300
$400
$500
$600
$700
$800
2015 2020 2023
Significant Debt Maturities
As of June 30, 2013
($ millions)
Page 13
Coupon Rates: 7.500% 7.375% 5.250%
*Pro Forma TTM for taxes on resin gain
Debt Maturities & Liquidity Summary – 6/30/13
Cash Balance = $392M
Net Debt / EBITDA* = 1.9x
• Repurchased
~3.0M shares
YTD in 2013
• 17 million shares
are available for
repurchase under
the current
authorization
Share
Repurchase
• Introduced a
quarterly dividend
in Q1 2011 and
increased in Q1
2012 (25%) and
Q1 2013 (20%)
• Objective of
maintaining and
growing
Dividends
• Expanding our
sales, marketing,
and technical
capabilities is top
priority
• Investing in
operational and
LSS initiatives
(including synergy
capture)
• CAPEX
Organic
Growth
• Targets that expand our:
• Specialty offering
• End market presence
• Geographic footprint
• Synergy opportunities
• Adjacent material solutions
• North American
manufacturing alignment
Acquisitions
*TTM 6/30/2013
Use of Cash
Page 14
Why Invest In PolyOne?
https://www.avient.com/sites/default/files/resources/TPE_Overmolding_Solutions_for_Engineering_Thermoplastics.pdf
Injection
velocity, 5 in/s
OM-1040 360
OM-1060 417
OM-1255 246
OM-1262 379
OM-6050-9 253
OM-6065-9 221
60A S-TPE 329
64A TPV 228
Table 5:
Materials
Temperature, C,
Nozzle/Front/Middle/Rear Mold Temperature, C Injection Hi Pressure, psi
OM1040 430/430/410/390 80 500
OM1060 430/430/410/390 80 600
OM1245 430/430/410/390 80 500
OM1262 430/430/410/390 80 800
OM6050 480/480/460/440 80 1000
OM6065 480/480/460/440 80 1200
B-TPE-35A 450/450/430/410 80 500
B-TPE-50A 450/450/430/410 80 800
B-TPE-65A 450/440/430/420 80 800
B.TPV-55A 480/480/470/460 80 800
B-TPV-55A 525/520/510/490 110 1500
B-TPV-70A 535/530/520/500/ 110 1500
Figure 2: Effect of overmold thickness on surface hardness on TPE products.
0.0
10.0
20.0
30.0
40.0
50.0
60.0
70.0
80.0
90.0
100.0
0 2 4 6 8 10
Thickness, mm
H
ar
dn
es
s,
S
ho
re
A
12
CL2000X
G6713
G7930
G7960
G7980
Adhesion Testing and Results
Design Considerations
Conclusions
https://www.avient.com/resources/safety-data-sheets?page=4567
MEDICAL PINK
https://www.avient.com/resources/safety-data-sheets?page=5742
ABS F-MEDICAL GREY-01
https://www.avient.com/resources/safety-data-sheets?page=4576
MEDICAL BIEGE
https://www.avient.com/resources/safety-data-sheets?page=2526
YELLOW MEDICAL